Thyrotropin-releasing hormone d,l polylactide nanoparticles (TRH-NPs) protect against glutamate toxicity in vitro and kindling development in vivo

Brain Research

Volumn 1303, Issue , 2009, Pages 151-160

  Veronesi, Michael C ^a   Aldouby, Yanir ^b   Domb, Abraham J ^b   Kubek, Michael J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Epilepsy; Intranasal; Kindling; Nanoparticles; Neuroprotection; TRH

Indexed keywords

GLUTAMIC ACID; NANOPARTICLE; POLYLACTIDE; PROTIRELIN;

AMYGDALOID NUCLEUS; ANIMAL CELL; ARTICLE; CLONUS; CONTROLLED STUDY; ELECTRODE; ELECTROENCEPHALOGRAPHY; EPILEPTOGENESIS; FEMALE; IN VITRO STUDY; IN VIVO STUDY; KINDLING; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOTYPY; TEMPORAL LOBE EPILEPSY;

ADMINISTRATION, INTRANASAL; AMYGDALA; ANIMALS; BIOLOGICAL AVAILABILITY; CELLS, CULTURED; DRUG DELIVERY SYSTEMS; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPSY, TEMPORAL LOBE; EVOKED POTENTIALS; GLUTAMIC ACID; HIPPOCAMPUS; KINDLING, NEUROLOGIC; NANOPARTICLES; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; POLYESTERS; RATS; RATS, SPRAGUE-DAWLEY; THYROTROPIN-RELEASING HORMONE; TREATMENT OUTCOME;

ANIMALIA; RATTUS;

EID: 71849104412     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.09.039     Document Type: Article

References (66)

1. Bertram E. The relevance of kindling for human epilepsy. Epilepsia 48 Suppl. 2 (2007) 65-74
2. Bishara A., and Domb A.J. PLA stereocomplexes for controlled release of somatostatin analogue. J. Control. Release 107 (2005) 474-483
3. Boler J., Enzmann F., Folkers K., Bowers C.Y., and Schally A.V. The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide. Biochem. Biophys. Res. Commun. 37 (1969) 705-710
4. Brewer G.J., Torricelli J.R., Evege E.K., and Price P.J. Optimized survival of hippocampal neurons in B27-supplemented neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35 (1993) 567-576
5. Chepurnov S.A., Chepurnova N.E., Abbasova K.R., and Goncharov O.B. Neuropeptide thyroliberin-an endogenous anticonvulsant in the brain. Usp. Fiziol. Nauk 33 (2002) 29-39
6. Domb A.J., and Kubek M.J. Synthesis of poly(carboxyphenoxypropane-sebacic anhydride) for delivery of drugs to the brain. In: Kobilar D., Lustig S., and Shapira S. (Eds). Blood Brain Barrier: Drug delivery and brain pathology (2001), Kluwar Academic Plenium Publishers, New York 351-362
7. Domb A., Maniar S., Bogdansky S., and Chasin M. Drug delivery to the brain using polymers. Crit. Rev. Ther. Drug Carr. Syst. 8 (1991) 1-17
8. Fail P.A., Anderson S.A., and Friedman M.A. Response of the pituitary and thyroid to tropic hormones in Sprague-Dawley versus Fischer 344 male rats. Toxicol. Sci. 52 (1999) 107-121
9. Gao X., Tao W., Lu W., Zhang Q., Zhang Y., Jiang X., and Fu S. Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration. Biomaterials 27 (2006) 3482-3490
10. Garat B., Miranda J., Charli J.L., and Joseph-Bravo P. Presence of a membrane bound pyroglutamyl amino peptidase degrading thyrotropin releasing hormone in rat brain. Neuropeptides 6 (1985) 27-40
11. Goddard G.V., McIntyre D.C., and Leech C.K. A permanent change in brain function resulting from daily electrical stimulation. Exp. Neurol. 25 (1969) 295-330
12. Guillemin R. Peptides in the brain: the new endocrinology of the neuron. Science 202 (1978) 390-402
13. Heuer H., Ehrchen J., Bauer K., and Schafer M.K. Region-specific expression of thyrotrophin-releasing hormone-degrading ectoenzyme in the rat central nervous system and pituitary gland. Eur. J. Neurosci. 10 (1998) 1465-1478
14. Hollenberg A.N. The role of the thyrotropin-releasing hormone (TRH) neuron as a metabolic sensor. Thyroid 18 (2008) 131-139
15. Inanaga K., Kumashiro H., Fukuyama Y., Ohtahara S., and Shirouzu M. Clinical study of oral administration of DN-1417, a TRH analog, in patients with intractable epilepsy. Epilepsia 30 (1989) 438-445
16. Jaworska-Feil L., Turchan J., Przewlocka B., Budziszewska B., Leskiewicz M., and Lason W. Effects of pilocarpine- and kainate-induced seizures on thyrotropin-releasing hormone biosynthesis and receptors in the rat brain. J. Neural Transm. 106 (1999) 395-407
17. Jaworska-Feil L., Kajta M., Budziszewska B., Leskiewicz M., and Lason W. Protective effects of TRH and its stable analogue, RGH-2202, on kainate-induced seizures and neurotoxicity in rodents. Epilepsy Res. 43 (2001) 67-73
18. Kastin A.J., and Pan W. Peptide transport across the blood-brain barrier. Prog. Drug Res. 61 (2003) 79-100
19. Knoblach S.M., and Kubek M.J. Thyrotropin-releasing hormone release is enhanced in hippocampal slices after electroconvulsive shock. J. Neurochem. 62 (1994) 119-125
20. Knoblach S.M., and Kubek M.J. Changes in thyrotropin-releasing hormone levels in hippocampal subregions induced by a model of human temporal lobe epilepsy: effect of partial and complete kindling. Neuroscience 76 (1997) 97-104
21. Knoblach S.M., and Kubek M.J. Increases in thyrotropin-releasing hormone messenger RNA expression induced by a model of human temporal lobe epilepsy: effect of partial and complete kindling. Neuroscience 76 (1997) 85-95
22. Kreider M.S., Engber T.M., Nilaver G., Zimmerman E.A., and Winokur A. Immunohistochemical localization of TRH in rat CNS: comparison with RIA studies. Peptides 6 (1985) 997-1000
23. Kubek M.J. Thyrotropin-releasing hormone: localization of specific hypothalamic and extrahypothalamic sites of CNS modulation. In: frederickson R.C.A., Hendrie H., Hingtgen J.N., and Aprison M. (Eds). Neuroregulation of autonomic, endocrine and immune systems (1986), Martinus-Nijhoff, Boston 265-301
24. Kubek M.J., and Garg B.P. Thyrotropin-releasing hormone in the treatment of intractable epilepsy. Pediatr. Neurol. 26 (2002) 9-17
25. Kubek M.J., and Sattin A. Effect of electroconvulsive shock on the content of thyrotropin-releasing hormone in rat brain. Life Sci. 34 (1984) 1149-1152
26. Kubek M.J., Lorincz M.A., and Wilber J.F. The identification of thyrotropin releasing hormone (TRH) in hypothalamic and extrahypothalamic loci of the human nervous system. Brain Res. 126 (1977) 196-200
27. Kubek M.J., Meyerhoff J.L., Hill T.G., Norton J.A., and Sattin A. Effects of subconvulsive and repeated electroconvulsive shock on thyrotropin-releasing hormone in rat brain. Life Sci. 36 (1985) 315-320
28. Kubek M.J., Low W.C., Sattin A., Morzorati S.L., Meyerhoff J.L., and Larsen S.H. Role of TRH in seizure modulation. Ann. N. Y. Acad. Sci. 553 (1989) 286-303
29. Kubek M.J., Knoblach S.M., Sharif N.A., Burt D.R., Buterbaugh G.G., and Fuson K.S. Thyrotropin-releasing hormone gene expression and receptors are differentially modified in limbic foci by seizures. Ann. Neurol. 33 (1993) 70-76
30. Kubek M.J., Liang D., Byrd K.E., and Domb A.J. Prolonged seizure suppression by a single implantable polymeric-TRH microdisk preparation. Brain Res. 809 (1998) 189-197
31. Kubek M., Ringel I., and Domb A.J. Issues related to intranasal delivery of neuropeptides to temporal lobe targets. In: Kobiler D., Lustig S., and Shapira S. (Eds). Blood-brain barrier: drug delivery and brain pathology (2001), Kluwar Academic/Plenum Publishers, New York 323-350
32. Kubek M.J., Domb A.J., and Veronesi M.C. Attenuation of kindled seizures by intranasal delivery of neuropeptide-loaded nanoparticles. Neurotherapeutics 6 (2009) 359-371
33. Kubek M.J., Yard M., Lahiri D.K., and Domb A.J. Characterization of Novel Intranasal Sustained-Release Nanoparticles for Delivery of Neuropeptides to the Brain. In: Domb A., Tabata Y., and Ravi Kumar N.V. (Eds). Nanoparticles for pharmaceutical applications (2007), American Scientific Publishers, New York 73-84
34. Langer R. Tissue engineering: a new field and its challenges. Pharm. Res. 14 (1997) 840-841
35. Lockman P.R., Mumper R.J., Khan M.A., and Allen D.D. Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev. Ind. Pharm. 28 (2002) 1-13
36. Loscher W. Animal models of intractable epilepsy. Prog. Neurobiol. 53 (1997) 239-258
37. Loscher W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res. 50 (2002) 105-123
38. Manaker S., Winokur A., Rostene W.H., and Rainbow T.C. Autoradiographic localization of thyrotropin-releasing hormone receptors in the rat central nervous system. J. Neurosci. 5 (1985) 167-174
39. Marklund N., Bakshi A., Castelbuono D.J., Conte V., and McIntosh T.K. Evaluation of pharmacological treatment strategies in traumatic brain injury. Curr. Pharm. Des 12 (2006) 1645-1680
40. Matsuishi T., Yano E., Inanaga K., Terasawa K., Ishihara O., Shiotsuki Y., Katafuchi Y., Aoki N., and Yamashita F. A pilot study on the anticonvulsive effects of a thyrotropin-releasing hormone analog in intractable epilepsy. Brain Dev. 5 (1983) 421-428
41. Matsumoto A., Kumagai T., Takeuchi T., Miyazaki S., and Watanabe K. Clinical effects of thyrotropin-releasing hormone for severe epilepsy in childhood: a comparative study with ACTH therapy. Epilepsia 28 (1987) 49-55
42. Matsumoto A., Kumagai T., Takeuchi T., Miyazaki S., and Watanabe K. Factors influencing effectiveness of thyrotropin-releasing hormone therapy for severe epilepsy in childhood: significance of serum prolactin levels. Epilepsia 30 (1989) 45-49
43. McNamara J.O., Bonhaus D.W., and Shin C. The kindling model of epilepsy. In: Schwartskroin P.A. (Ed). Epilepsy models, mechanisms and concepts (1993), Cambridge University Press, Cambridge 27-47
44. Momiyama T., Ishihara K., Kimura K., Todo N., Fujita Y., Serikawa T., and Sasa M. Long-term antiepileptic effects of chronic intake of CNK-602A, a thyrotropin-releasing hormone analogue, on spontaneously epileptic rats. Epilepsia 37 (1996) 328-331
45. Nillni E.A., and Sevarino K.A. The biology of pro-thyrotropin-releasing hormone-derived peptides. Endocr. Rev. 20 (1999) 599-648
46. Oberdorster G., Sharp Z., Atudorei V., Elder A., Gelein R., Kreyling W., and Cox C. Translocation of inhaled ultrafine particles to the brain. Inhal. Toxicol. 16 (2004) 437-445
47. Ogawa N., Hirose Y., Mori A., Kajita S., and Sato M. Involvement of thyrotropin-releasing hormone (TRH) neural system of the brain in pentylenetetrazol-induced seizures. Regul. Pept. 12 (1985) 249-256
48. Paxinos G., and Watson C. The rat brain in stereotactic coordinates. 2nd edn. (2006), Academic Press, Orlando
49. Pekary A.E., Sattin A., and Lloyd R.L. Electroconvulsive seizures increase levels of PS4, the TRH-enhancing peptide [prepro-TRH(160-169)], in rat brain. Neuroendocrinology 65 (1997) 377-384
50. Pizzi M., Boroni F., Benarese M., Moraitis C., Memo M., and Spano P. Neuroprotective effect of thyrotropin-releasing hormone against excitatory amino acid-induced cell death in hippocampal slices. Eur. J. Pharmacol. 370 (1999) 133-137
51. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32 (1972) 281-294
52. Rosen J.B., Cain C.J., Weiss S.R., and Post R.M. Alterations in mRNA of enkephalin, dynorphin and thyrotropin releasing hormone during amygdala kindling: an in situ hybridization study. Brain Res. Mol. Brain Res. 15 (1992) 247-255
53. Sakai S., Baba H., Sato M., and Wada J.A. Effect of DN-1417 on photosensitivity and cortically kindled seizure in Senegalese baboons, Papio papio. Epilepsia 32 (1991) 16-21
54. Schally A.V. Aspects of hypothalamic regulation of the pituitary gland. Science 202 (1978) 18-28
55. Schmutz M., and Klebs K. Kindling and antiepileptic drugs. In: Bowig T.G., and Trimble M.R. (Eds). The clinical relevance of kindling (1989), Wiley, New York 55-68
56. Sutula T.P. Experimental models of temporal lobe epilepsy: new insights from the study of kindling and synaptic reorganization. Epilepsia 31 Suppl. 3 (1990) S45-S54
57. Takeuchi Y., Tominaga M., Mitsufuji N., Yamazoe I., Kawase S., Nishimura A., Matsuo S., and Sawada T. Thyrotropin-releasing hormone in treatment of intractable epilepsy: neurochemical analysis of CSF monoamine metabolites. Pediatr. Neurol. 12 (1995) 139-145
58. Takeuchi Y., Matsushita H., Kawano H., Sakai H., Yoshimoto K., and Sawada T. TRH increases cerebrospinal fluid concentration of kynurenine. NeuroReport 10 (1999) 3601-3603
59. Takeuchi Y., Takano T., Abe J., Takikita S., and Ohno M. Thyrotropin-releasing hormone: role in the treatment of West syndrome and related epileptic encephalopathies. Brain Dev. 23 (2001) 662-667
60. Tanaka C., Maegaki Y., Koeda T., Ohta S., and Takeshita K. Successful treatment of progressive myoclonus epilepsy with TRH. Pediatr. Neurol. 18 (1998) 442-444
61. Veronesi M.C., Kubek D.J., and Kubek M.J. Intranasal delivery of a thyrotropin-releasing hormone analog attenuates seizures in the amygdala-kindled rat. Epilepsia 48 (2007) 2280-2286
62. Veronesi M.C., Yard M., Jackson J., Lahiri D.K., and Kubek M.J. An analog of thyrotropin-releasing hormone (TRH) is neuroprotective against glutamate-induced toxicity in fetal rat hippocampal neurons in vitro. Brain Res. 1128 (2007) 79-85
63. Veronesi M.C., Kubek D.J., Domb A.J., and Kubek M.J. 29th Annual Winter Neuropeptide Conference (2008), Breckenbridge, CO
64. Wan R.Q., Noguera E.C., and Weiss S.R. Anticonvulsant effects of intra-hippocampal injection of TRH in amygdala kindled rats. NeuroReport 9 (1998) 677-682
65. Winokur A., and Utiger R.D. Thyrotropin-releasing hormone: regional distribution in rat brain. Science 185 (1974) 265-267
66. Zhang X., Klueber K.M., Guo Z., Cai J., Lu C., Winstead W.I., Qiu M., and Roisen F.J. Induction of neuronal differentiation of adult human olfactory neuroepithelial-derived progenitors. Brain Res. 1073-1074 (2006) 109-119